美股、中概股下挫，小鹏跌超3%，蔚来、理想跌超2%，黄金原油短线跳水

Market Overview - US stock market opened slightly lower with the Dow Jones down 0.03%, S&P 500 down 0.02%, and Nasdaq down 0.13% [1] - The Philadelphia Semiconductor Index fell by 0.62%, while Nvidia saw a slight increase of 0.34% [3] Company Highlights - Novo Nordisk's GLP-1 drug, semaglutide oral version, received FDA approval, leading to a significant stock increase of 9.5%. The drug is set to launch in the US in early January [3] - The Nasdaq Golden Dragon China Index dropped by 1.2%, with major Chinese stocks under pressure, including XPeng down over 3.7% and others like NIO, Li Auto, and Bilibili down over 2% [3][4] Cryptocurrency Market - Multiple cryptocurrencies experienced a collective decline, with Bitcoin falling below $87,000, resulting in over 90,000 liquidations globally within 24 hours [9][10] Economic Indicators - The US Commerce Department reported a preliminary estimate showing a 4.3% annualized growth in GDP for Q3, with increases in exports and consumer spending, but declines in investment and imports [10]